Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-25-004826
Filing Date
2025-07-30
Accepted
2025-07-30 16:12:28
Documents
81
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q anik20250630_10q.htm   iXBRL 10-Q 1453556
2 EXHIBIT 31.1 ex_842658.htm EX-31.1 12695
3 EXHIBIT 31.2 ex_842659.htm EX-31.2 12722
4 EXHIBIT 32.1 ex_842660.htm EX-32.1 4045
  Complete submission text file 0001171843-25-004826.txt   7329338

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA anik-20250630.xsd EX-101.SCH 63166
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE anik-20250630_def.xml EX-101.DEF 425673
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE anik-20250630_lab.xml EX-101.LAB 375053
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anik-20250630_pre.xml EX-101.PRE 470094
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE anik-20250630_cal.xml EX-101.CAL 55258
84 EXTRACTED XBRL INSTANCE DOCUMENT anik20250630_10q_htm.xml XML 1233946
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14027 | Film No.: 251167174
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)